Cafepharma Today

May 28 2025 - GLP-1 prescriptions for weight loss soar, despite obstacles
GLP-1 prescriptions for weight loss soar, despite obstacles
FDA approves use of Sanofi's meningococcal vaccine in infants
GSK's $66M bet on Spero's rejected UTI antibiotic pays off with a phase 3 win
AbbVie's Allergan Aesthetics unit plots 202 layoffs after recent sales slide
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Protalix rallies following report of takeover talks
Yahoo/Fly on the Wall
Tuesday, February 5, 2013 - 10:50am
tags:
Protalix, M&A, Pfizer
Alas, Hamlet! A Diabetes Drugmaker to Renew the Faith
Motley Fool
Tuesday, February 5, 2013 - 10:49am
tags:
diabetes, Novo Nordisk
Gilead Earnings Blaze a Star-Studded Future
Motley Fool
Tuesday, February 5, 2013 - 10:39am
tags:
earnings, Gilead
Idenix Pharma ends development of 2 hepatitis C drugs after regulators signal further holds
Yahoo/AP
Tuesday, February 5, 2013 - 10:38am
tags:
Idenix, hepatitis C, IDX184, IDX19368
3 Things to Watch at Momenta Pharmaceuticals
Motley Fool
Tuesday, February 5, 2013 - 10:34am
tags:
Momenta
Pipeline Progress at Glaxo
Yahoo/Zacks
Tuesday, February 5, 2013 - 10:33am
tags:
GSK, dabrafenib, melanoma
Sanofi's New Diabetes Play Moves Forward
Motley Fool
Tuesday, February 5, 2013 - 10:30am
tags:
Sanofi, diabetes, Lyxumia, GLP-1 agonist
A Closer Look At Keryx Biopharmaceuticals' Phase III Result Announcement
Seeking Alpha
Tuesday, February 5, 2013 - 10:28am
tags:
Keryx, kidney disease, Zerenex
FDA approves generic version of cancer drug Doxil
Reuters
Tuesday, February 5, 2013 - 10:27am
tags:
FDA, generics, Doxil, Sun Pharma, JNJ, ovarian cancer, Multiple Myeloma
Feds grab Shire's attention on Adderall marketing
Fierce Pharma
Monday, February 4, 2013 - 12:23pm
tags:
Shire, Adderall, ADHD
American consumers approach court to consider recall of Ranbaxy's generic drug Lipitor
Economic Times, India
Monday, February 4, 2013 - 12:22pm
tags:
generics, Ranbaxy, Lipitor, Pfizer, recalls
No Sunshine On Continuing Medical Education?
Pharmalot
Monday, February 4, 2013 - 12:21pm
tags:
physicians, CME, Physician Payment Sunshine Act
Pfizer's 2013 Potential Growth Catalysts
Seeking Alpha
Monday, February 4, 2013 - 12:19pm
tags:
Pfizer, Xeljanz, Bosutinib, Eliquis, PD-0332991
Is Delcath The Post-Celsion Play On Liver Cancer?
Seeking Alpha
Monday, February 4, 2013 - 12:18pm
tags:
Delcath, liver cancer, Celsion, Chemosat
Gilead's 2 hepatitis C drug trials meet study goals
Reuters
Monday, February 4, 2013 - 12:17pm
tags:
Gilead, hepatitis C, Neutrino, Fission
The Medicines Co., Alnylam form strategic alliance to develop RNAi Therapeutics
Yahoo/Fly on the Wall
Monday, February 4, 2013 - 12:14pm
tags:
RNAi, Alnylam, Medicines Company
Trius Therapeutics: Takeover Candidate In 2013
Seeking Alpha
Monday, February 4, 2013 - 12:13pm
tags:
Trius Therapeutics, Cubist Pharmaceuticals, M&A
SciClone Pharmaceuticals: A Promising Biotech Stock
Seeking Alpha
Monday, February 4, 2013 - 12:12pm
tags:
SciClone
Depomed Bear Case: FDA Panel Will Ding Serada
Yahoo/TheStreet.com
Monday, February 4, 2013 - 12:08pm
tags:
Depomed, FDA, Serada
Teva Pharmaceutical Industries Earnings Are on Deck
Motley Fool
Monday, February 4, 2013 - 12:07pm
tags:
Teva, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.